Given the inhibitory role of TRIM26 in regulating CEBPD-associated signalling, the in vitro and in vivo results compelled us to detect another important concern: whether and how TRIM26 binds to CEBPD in the context of NASH progression. This evidence concerns the gene CEBPD and metabolic dysfunction-associated steatohepatitis.